99mTc-MIRC208 SPECT/CT Imaging for HER2-Positive Cancer Patients
Condition: Cancer Intervention: Drug: 99mTc-MIRC208 Sponsor: Beijing Cancer Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials